Assessing the Performance of 18F-FDG PET/CT in Bladder Cancer: A Narrative Review of Current Evidence.

Mara Bacchiani,Vincenzo Salamone,Eleana Massaro,Alessandro Sandulli,Riccardo Mariottini,Anna Cadenar,Fabrizio Di Maida,Benjamin Pradere,Laura S Mertens,Mattia Longoni,Wojciech Krajewski,Francesco Del Giudice,David D'Andrea,Ekaterina Laukhtina,Shahrokh F Shariat,Andrea Minervini,Marco Moschini,Andrea Mari, On Behalf Of European Association Of Urology-Young Academic Urologists Eau-Yau Urothelial Carcinoma Working Group

Cancers（2023）

引用 2|浏览4

暂无评分

摘要

18F-FDG PET/CT provides important incremental staging and restaging information that can potentially influence clinical management in MIBC patients. Standardization and development of a scoring system are necessary for its wider adoption. Well-designed randomized controlled trials in larger populations are necessary to provide consistent recommendations and consolidate the role of 18F-FDG PET/CT in the management of bladder cancer patients.

查看译文

关键词

bladder cancer,lymph node,FDG PET/CT,staging,restaging

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要